Showing results (21-30 of 255) with videos related to

Sort By:
Pageof 26
European Journal of Clinical Pharmacology|August 11, 1998
Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled release [corrected] in parkinsonian patientsM Contin, R Riva, P Martinelli, et al.
Therapeutic Drug Monitoring|January 1, 1985
Determination of total and free plasma carbamazepine concentrations by enzyme multiplied immunoassay: interference with the 10,11-epoxide metaboliteM Contin, R Riva, F Albani, et al.
Epilepsia|February 1, 1983
Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serumF Albani, R Riva, G Procaccianti, et al.
Therapeutic Drug Monitoring|January 1, 1982
Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patientsR Riva, F Albani, A Baruzzi, et al.
Clinical Neuropharmacology|December 1, 1992
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's diseaseM Contin, R Riva, P Martinelli, et al.
Headache|May 1, 1990
Flunarizine plasma concentrations and side effects in migraine patientsF Albani, A Baldrati, P Cortelli, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's diseaseM Contin, R Riva, P Martinelli, et al.
Epilepsy Research|September 28, 2011
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsyM Contin, S Mohamed, F Albani, et al.
Therapeutic Drug Monitoring|June 1, 1983
Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patientsR Riva, F Albani, P Cortelli, et al.
Epilepsia|July 1, 1985
Free and total serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in infancy and childhoodR Riva, M Contin, F Albani, et al.
Pageof 26